Eli Lilly halts India obesity awareness campaign after regulatory scrutiny, seeks rules clarity
Published on: May 12, 2026, 6:57 a.m. | Source: The Economic Times
Eli Lilly halted its obesity awareness campaign in India. The nation's drug regulator cautioned the company about potential violations. The campaign aimed to reframe obesity as a chronic disease. It featured various media without naming specific products. Lilly cited regulatory uncertainty and conflicting guidance. The regulator's advisory prohibited indirect promotion of medicines. This pause impacts a public health initiative.
